Drug General Information (ID: DDITIZJ5O6)
  Drug Name Diroximel fumarate Drug Info Trastuzumab deruxtecan Drug Info
  Drug Type Small molecule Monoclonal antibody
  Therapeutic Class Selective Immunosuppressants Antineoplastics/Her2 Inhibitors

 Mechanism of Diroximel fumarate-Trastuzumab deruxtecan Interaction (Severity Level: Moderate)
     Additive immunosuppressive effects Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Diroximel fumarate Trastuzumab deruxtecan
      Mechanism Immunosuppressive effects Immunosuppressive effects
      Key Mechanism Factor 1
Factor Name Immunosuppressive effects
Factor Description Immunosuppression is when your immune system is not functioning as it should. The immune system is made up of cells, tissues and organs that help the body fight off infections. If the immune system is suppressed, an infection that your body was able to control may become serious or even fatal.
      Mechanism Description
  • Additive immunosuppressive effects by the combination of Diroximel fumarate and Trastuzumab deruxtecan 

Recommended Action
      Management The safety and efficacy of monomethyl fumarate, dimethyl fumarate, or diroximel fumarate in combination with other immunosuppressive or myelosuppressive agents have not been evaluated. Until further information is available, concomitant use should be avoided if possible.

References
1 Product Information. Vumerity (diroximel fumarate). Alkermes, Inc, Cambridge, MA.